Trial Profile
A comparison of the efficacy of once-daily fluticasone furoate/vilanterole with twice-dily fluticasone propionate/salmeterol in elderly patients with asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Aug 2018
Price :
$35
*
At a glance
- Drugs Vilanterol/fluticasone furoate (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- 16 Aug 2018 Status changed from not yet recruiting to completed.
- 06 Apr 2015 New trial record